Early Access — free while we kick the tires
EdgarHawk

MCGIRR DAVID W J

Director

Director
1 filing analyzed · 1 company · Latest 2025-06-05

Companies

Company Buys Sells Direction
RHYTHM PHARMACEUTICALS, INC. RYTM 0 3 Net selling

Activity

June 2025
high
Sell
65,431 shares
$4,267,494
Significance 7/10

Director McGirr sells 65,431 shares (95.6% of holdings) at $65.22 avg; retains 3,000 shares

Director David W. J. McGirr executed 2 separate sales on 2025-06-03, disposing of 65,431 shares (95.6% of his pre-transaction holdings of 68,431 shares) for a blended average price of $65.22, raising $4,267,494.07. He retains only 3,000 shares post-transaction. This near-complete exit occurs as the stock trades at $66.18, within 1.7% of its 52-week high of $67.33, after a 30-day gain of +5.5% and 90-day surge of +30.3%. The company reported revenue growth of +68.1% year-over-year but remains unprofitable, with a net loss of $49,498,000 in the latest fiscal year against quarterly revenue of $32,704,000. The magnitude of the liquidation—reducing holdings by 95.6%—combined with the timing near the stock's 52-week highs amid strong recent price momentum, represents a substantial reduction in insider equity exposure at a significant valuation level.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access